Oxford, UK – 24 March 2021. OGT, a Sysmex Group Company, is today unveiling a brand refresh and new integrated website that reaffirms and pledges its commitment to delivering partnership, innovation and expertise to scientists and clinical decision makers worldwide. The new integrated website reflects this commitment by delivering substantial resources, support and tools along with an intuitive and seamless customer journey.
The brand refresh has been driven by a desire to fully integrate the company’s three well-known brands of innovative genomics solutions—CytoCell® FISH probes, CytoSure® array and NGS products and SureSeq™ NGS panels—to enhance customer experience, but also to crystalize and communicate OGT’s drive and dedication to helping its customers progress genetic-based medicine. This is something that the company is already well known for—in particular the level of expertise of its staff—as Dr Adam Smith, Director at the Cancer Cytogenetics Laboratory, University Health Network in Toronto noted, “OGT provides industry best customer service. Our use of CytoCell probes is in no small part due to the excellent service, delivery speed and rapid response to any technical problem we have.”
The company’s new tag-line—What binds us, makes us—is an elegant summation of OGT’s mission to offer partnership to its customers, and its vision that sharing knowledge and expertise is key to unlocking the future of genetic clinical care and improving patient lives. As true pioneers in hybridization technology (OGT was founded by Professor Sir Edwin Southern, creator of the Southern blot) the tag-line also reflects this unique and extensive hybridization expertise that runs through the core of the company and indeed its entire product portfolio.
The messaging is evidenced by the extensive support provided by OGT scientists during the COVID-19 pandemic. John Anson, CEO of OGT commented: “Our team of scientists quickly adapted to delivering above-and-beyond remote support—providing technical check-ins, troubleshooting, workflow optimization and video calls to assist with training. In one instance a member of our team even watched a robot run an assay via video for a number of hours to help troubleshoot. It’s remarkable because while we’ve always had this level of commitment to our customers, we had to find new approaches to be able to provide the same levels of support. While this has been a real strength during COVID-19, it’s our pledge that it will reach far, far beyond. Our brand refresh and new website underline partnership as a key approach that we’re very much dedicated to.”
Further evidencing OGT’s commitment to customer support, the new website provides customers with substantial education and resources sections. The search function has also been updated to allow filtering of products by disease, gene or chromosome of interest and OGT’s entire range of FISH, NGS and array products are now listed with easy access to associated documentation, including instructions for use, certificates of analysis and product brochures.
As part of the Sysmex group, OGT’s reach is significant, enabling it to bring its offer of partnership to researchers and clinicians worldwide and deliver these partners the tools and support they need to advance genomic medicine.
OGT, a Sysmex Group company, is a leading global provider of clinical and diagnostic genomic solutions that are created for scientists by scientists - including CytoCell, CytoSure and SureSeq ranges of FISH, microarray and NGS products. The company is dedicated to creating products that enable researchers and clinical decision makers to reach the right care decisions for each patient, every time. OGT strives to unlock the future of genetic clinical care with a commitment to working in partnership with its customers - not only by sharing its expertise of 25 years at the forefront of genetic endeavor, but also by working closely with scientists to understand their unique challenges, and to customize its approach to meet their exact needs. Dedicated to improving clinical care, OGT believes that through partnership—together—we’ll achieve more
CytoSure®, SureSeq™ and myProbes®: For Research Use Only, not for use in diagnostic procedures. CytoCell®: Some products may not be available in your region.
Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 50 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for cell, gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, the Middle East, Africa, China and Asia Pacific and employs more than 9,000 employees worldwide. Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange.
For more information about Sysmex Corporation and its affiliate companies, please visit www.sysmex.co.jp/en/
MDSAP certification of new Cambridge facility smooths path to future IVD approvals.Read